2025.02. – 2026.11. Co-principal Investigator

• Research on immunotoxicity testing methods for pharmaceuticals.

• Ministry of Food and Drug Safety (MFDS).

2022.07. – 2023.06. Principal Investigator

• Efficacy evaluation in tumor cells and tumor-bearing animal models using unknown inhibitor derivatives.

• FromBIO Corp. 

2022.02. – 2024.11. Co-principal Investigator

• Immunotoxicity study of nanomaterials for the food and drug safety.

• Ministry of Food and Drug Safety (MFDS).

2021.04. – 2022.03. Principal Investigator

• Efficacy Evaluation in Allergic Disease Animal model Using Human Embryonic Stem Cell-derived Mesenchymal Stem Cells.

• MIRAE CELL BIO Corp. 

2020.09. – 2027.08. Participating professor

• Convergence Health Care Center for Future Environmental Hazards.

• 4th Brain Korea 21 (BK21 FOUR) program by National Research Foundation of Korea (NRF). 

2020.03. – 2025.02. Principal Investigator

• Functional Study of new Innate Immune Regulatory Cells in Inflammation and Cancer Diseases.

• Young Researcher program by National Research Foundation of Korea (NRF).

• First Innovation Lab program by National Research Foundation of Korea (NRF).  

2017.06. – 2020.05. Principal Investigator

• Study for Epigenetic Regulatory Mechanism of Regulatory B Cells in Inflammatory Diseases.

• General Research program by National Research Foundation of Korea (NRF). 

2015.09. – 2016.08. Co-Researcher

• Study for Immune Regulatory Mechanisms of Regulatory B Cells in Allergy Immune Tolerance.

• Strategic Research program by National Research Foundation of Korea (NRF). 

2013.11. – 2016.10. Principal Investigator

• Study for Immune Regulatory Mechanisms of Regulatory B Cells in Autoimmune Diseases.

• General Research program by National Research Foundation of Korea (NRF). 

2013.11. – 2018.10. Co-Researcher

• Laboratory of Integrated Immunoregulation.

• Basic Research Laboratory (BRL) program by National Research Foundation of Korea (NRF).